Egypt’s Grinta Expands to Primary Care With Citi Clinic Acquisition
Egyptian pharma-tech startup Grinta is shifting its focus from B2B retail distribution to expand into primary healthcare.
Egyptian healthtech startup Grinta has announced its acquisition of Citi Clinic, a primary healthcare service chain based in Egypt, marking a strategic shift from B2B pharmaceutical distribution to direct patient care.
As part of this transition, Grinta has also secured a strategic funding round from Beltone Venture Capital and Raed Ventures, though the investment amount remains undisclosed.
By acquiring Citi Clinic, Grinta gains access to a network of over 150,000 patients, integrating offline and online healthcare services. This move reflects a broader industry trend, with major pharmaceutical players like McKesson and Walgreens also transitioning into direct-to-consumer healthcare services.
Beyond Egypt, Grinta is expanding its East African footprint, with plans to build a pharmacy chain in Tanzania and develop export partnerships with Egyptian pharmaceutical manufacturers.
- Previous Article UAE-Based PlaysOut Raises $7M Seed Round to Expand Blockchain Gaming
